chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The blood pressure went up after they took the shot; I had my second dose on the 9th of February, it keeps going up; This is a spontaneous report from a contactable consumer(patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 09Feb2021 as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The historical vaccine include bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. The patient experienced the blood pressure went up after they took the shot and had the second dose on the 9th of February, it keeps going up on an unspecified date. Reporter wanted to know does anyone reported that the blood pressure went up after they took the shot (Covid-19 Vaccine) had the Pfizer shot. The patient underwent lab test and procedures and found blood pressure increased. The event outcome was reported as unknown.   Follow-up attempts are completed. No further information is expected.
After giving vaccine the Medical assistant went to close cap on needle and poked herself. Medical Assistant went to the emergency room and  had labs drawn.  We are still in the process of obtaining consent from the patient to have labs drawn. These needs have been a consistent problem.  This is the first needle stick injury to occur.   safety needle.  ref # lot# 210410.  We have pulled these needles from our stock which was delivered as part of the ancillary stock for Covid vaccines.
Redness on (L) arm extending from deltoid to approx. the elbow. Temp of 100 degrees x2 days. Pain with use of (L) arm. Took BENADRYL which helped some. Pt was diagnosed with cellulitis by ARNP and tx with antibiotic.
High fever, Weakness, body sore to touch ( sensitive), tired. Headaches ( horrible). starting about 10 hours later after shot.Till Saturday ( three days later..
Right side of chest hurts; Is tired; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), in Feb2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHEST PAIN (non-serious) with onset 08Feb2023, outcome "not recovered", described as "Right side of chest hurts"; HEADACHE (non-serious) with onset 2023, outcome "not recovered"; FATIGUE (non-serious) with onset 2023, outcome "unknown", described as "Is tired".  Additional information: It was reported that the patient took first dose of Pfizer Covid Vaccine last Friday. Unable to confirm the date of last Friday due to caller declining to complete the report. Had to get Pfizer Covid Vaccine for a job at the hospital. The patient had a headache every day since and could not get rid of headache. Then yesterday, 08Feb2023 and today, 09Feb2023, the right side of chest hurts.  The patient wanted to know what needed to do or was something serious. She was tired of being on hold. She also reported she would deal with it and if got serious would go to hospital.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Change in taste sense; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Change in taste sense) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Change in taste sense). At the time of the report, DYSGEUSIA (Change in taste sense) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  On an unknown date, the patient experienced change in taste sense. The patient has done multiple COVID tests with results returned negative. No treatment information was provided.   Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Roughly three hours post-injection, I began experiencing severe intramuscular pain at the injection site (similar in intensity to the feeling of a dislocated shoulder or a fractured bone), which for the next 12 hours was so unremitting and extreme, I was unable to sleep. After 12 hours, while the intensity of the pain remained the same, it only occurred when I engaged the muscle of that arm, so that for the next two days, if I needed to use my left hand at all, I used my right arm to lift it. It has now been three days since the vaccination. And though I can lift my left arm now without assistance, it still hurts to do so, though significantly less than it had initially.
Employee reports approximately 12:30am she experience new onset of headache, body ache, chills, and fatigue.  She stated that she took otc mortin and her symptoms shortly after resolved.
ABOUT 7-8 MINUTES IN TO 15 MINUTE MONITORING TIME PATIENT GOT EXTREMELY SWEATY, STATED HE FELT LIGHT HEADED AND SICK. PATIENT THREW UP.  PATIENT STATED HE FELT BETTER AFTER THE EMISIS.  PATIENT STATED HE HAD EATEN EARLIER IN THE DAY.  BP 122/72. PULSE 69. OXYGEN SATURATION 99%
13 YEAR OLD PATIENT WAS PROVIDED PFIZER VACCINE FOR 5-11 YEAR OLD POPULATION.
Shaking and nervousness started  3 hours after vaccination.  Vital signs stable: HR: 87 BP:121/87 O2:98
Small rough bumps on right arm, raised whelps that itched and spread through the body,  joint aches in legs and arms, sensitivity in lymph nodes in neck, fluid retention underneath both eyes
Patient c/o Numbness of the peri-oral numbness within 5 minutes of getting the vaccaine, strange taste in the mouth soon after the vaccine. Patient had taken Benadryl , pressure in the eyes and tightness in the chest. Patient continues to have mild episodic vertigo since then.
Hemorrhagic Stroke on 07/30/2021 died 08/03/2021
Swollen hands and feet severe pain; Swollen hands and feet severe pain; hurts to walk; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen hands and feet severe pain), PAIN IN EXTREMITY (Swollen hands and feet severe pain) and GAIT DISTURBANCE (hurts to walk) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054cz1a and 006d21a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen hands and feet severe pain), PAIN IN EXTREMITY (Swollen hands and feet severe pain) and GAIT DISTURBANCE (hurts to walk). At the time of the report, PERIPHERAL SWELLING (Swollen hands and feet severe pain) and PAIN IN EXTREMITY (Swollen hands and feet severe pain) had not resolved and GAIT DISTURBANCE (hurts to walk) outcome was unknown.            Concomitant medication were not provided. Treatment medication were not reported.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
no adverse effects; the patient was inadvertently administered a dose of MMR II via the intramuscular route rather than the recommended subcutaneous route; This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Information about the patient's medical history, concurrent conditions, concomitant medications and drug reactions or allergies was not provided.      On 25-MAR-2019, the patient was inadvertently vaccinated wit a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (rHA)(lot # N020926 with an expiration date in 01-AUG-2019), via intramuscular route rather than the recommended subcutaneous, for prophylaxis (strength, dose and frequency were no provided). No adverse effects were reported.
Patient stopped talking in mid sentence and became unresponsive.  She then collapsed to the floor (passed Out).  she was out for about 30 seconds.  Noticed a tingling in her feet.  She was transported to the ER via ambulance.  They did EKG, Chest X-Ray, Blood work and a few other tests.  No treatment given besides keep an eye on her for the next couple of days.
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. No medical history and concurrent conditions reported. On 05-JUN-2015, the patient was inadvertently administered with improperly stored MMR II vaccine, lot # K002528, expire date: 18-Feb-2016, (dose, route, therapy type not reported). No adverse effects reported. No product quality complaint reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report as received from a other health professional refers to unspecified patients of unknown age and gender. The patients pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date the patients were vaccinated with improperly stored with GARDASIL 9 (strength, dose, frequency and route of administration were not reported) lot # L011846 with an expiry date of 16-JUN-2017, lot # L01628 with an expiry date of 30-JUL-2017 and lot # 04-MAR-2017. No concomitant medications were reported. No adverse effects were reported. There was no product quality complaint. This is one of the two reports from the same reporter. Additional information has been requested.
FLESHY KIND OF COLORED TURNS WHITE WHEN PUSHED ON IT; RASH FROM ELBOW TO WRIST INSIDE OF FOREARMS A LITTLE BIT OF THE CHEST NEAR V NECK SHAPED, MIDDLE OF NECK TO TOP OF BREAST AREA/RASH ON BOTH ARMS; PAIN DURING INJECTION OF SHOT; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821281, and expiry: UNKNOWN) dose was not reported, administered on 01-JUN-2021 16:00 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced fleshy kind of colored turns white when pushed on it, rash from elbow to wrist inside of forearms a little bit of the chest near v neck shaped, middle of neck to top of breast area/rash on both arms, and pain during injection of shot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the rash from elbow to wrist inside of forearms a little bit of the chest near v neck shaped, middle of neck to top of breast area/rash on both arms, pain during injection of shot and fleshy kind of colored turns white when pushed on it was not reported. This report was non-serious.
Tinnitus which was chronic at a 3/10 intensity in L. ear within one week became 9/10 intensity
ED to Hosp-Admission  Discharged   9/14/2021 - 9/17/2021 (3 days)   Last attending ? Treatment team Pneumonia due to COVID-19 virus   History of Present Illness    Sent from urgent care after she tested positive for COVID-19 Patient is an 83 y.o. female.    Presented to the ER for evaluation of chills, sore throat, cough and loss of appetite.  Patient reported exposure to COVID-19.  The source of COVID-19 is her son who was admitted to the hospital.  Patient has been symptomatic for about a week.  Patient also is complaining of myalgia and loss of smell and taste.  Patient also reported diarrhea but no vomiting.  She denies abdominal pain.  She was seen at urgent care today.Patient tested positive for COVID-19 in urgent care. Patient received vaccination for Covid 19 in May , 2021. Patient also reported significant weakness and fatigue.   Vitals showed low-grade fever, tachycardia, accelerated hypertension, patient oxygen saturation is 99 and was put on oxygen via nasal cannula.   Labs, reviewed CBC and CMP and showed GFR of 69.4 with normal BUN and creatinine otherwise unremarkable.   CRP was 153.1. Lactic acid level was 1.2 and was normal. COVID-19 was positive. Blood culture was collected Chest x-ray showed right lower lobe infiltrate. EKG was normal   Review of Systems  Constitutional: Positive for activity change, chills and fatigue.  HENT: Negative.   Eyes: Negative.   Respiratory: Positive for cough and shortness of breath.   Cardiovascular: Negative.   Gastrointestinal: Positive for diarrhea.  Endocrine: Negative.   Genitourinary: Negative.   Musculoskeletal: Negative.   Skin: Negative.   Allergic/Immunologic: Negative.   Neurological: Positive for weakness.  Psychiatric/Behavioral: Negative.
About 5 mins after the vaccine was given, the patient started experiencing, rapid heartbeat, feeling weird, hot, thought her tongue was starting to feel thick. The pharmacist gave the patient 50 mg of BENADRYL with a glass of water. In about 5 mins the adverse reaction started to subside, the pharmacist took the patients BP. It was within normal limits. The patient stayed in the pharmacy for about 15 more mins, and left feeling better. She came in the next day with a big red rash around and at the injection site, she was encouraged to continue taking the BENADRYL as needed.
ADMINISTERD HPV IN R ARM. STEPPED  TO PATIENT'S LEFT SIDE TO ADMINISTER MENINGOCOCCAL VACICNE INTO  L ARM., BUT I NEVER GAVE MENINGOCOCCAL VACCINE.  PATIENT ASKED "AM I SUPPOSE TO FEEL NAUSATED?" THEN, PATIENT BECAME UNCONCIOUS WITH  RIGID  SEIZURE LIKE ACTIVITY NOTED. PATIENT REGAINED COUNSCIOUSNESS IN LESS THAN 30 SECONDS, BUT STILL C/O OF NAUSEA.  COOL TOWEL TO FOREHEAD.  B/P 87/60. PULSE 69. 911 CALLED.  TRANSPORTED TO LOCAL HOSPITAL.
I had the flu shot on 10/15/19 at my workplace. The person who administered the shot was a college student (which we were not informed in any way that they were using students).   The female young student was like 5ft 10? tall who administered the shot while I was sitting and she was standing.  I was sitting on a normal folding chair.  She made my arm twitch twice.  As the day followed my arm started to feel in so much pain by 7pm.  By 10pm I couldn?t move my arm and the pain was not bearable so I took pain pills.  I work at my desk on my computer for 8hrs.  So the next morning I was good but as the day progressed my right arm started hurting.  And the pain went from my right back neck all the way to my right palm.
I was okay until the second week. Then I developed a rash the size of my fist that was raised red and itchy. The doctor called it "COVID" arm and prescribe a medicated cream.
pt devel maculopapular rash on face, & body same day as vax;T96.6;maculopapular rash;
In Feb2021 or Mar2021, the 33 yr old caucasian male, with a medical history of Depression, bipolar, anxiety, concomitant medications include Focalin, Viibryd, and unspecified mood stabilizers, received the COVID-19 vaccine by Pfizer in an unspecified arm.  On 12Aug2021, he bought the Abbott's  BinaxNOW COVID-19 Ag Card for him and his mom, his mom tested positive for COVID-19 and he tested Negative.  On 14Aug2021, in the evening, he was experiencing stuffy nose, headache, aches, and fever. On 15Aug2021, approx. 5pm EST, he took another test and tested positive, experiencing stuffy nose, headache, aches, but the fever resolved. The outcome of the events were unknown.  The reporter (Registered Nurse) assessed this lack of effect and COVID-19 vaccination failure as absolutely related to the COVID-19 Pfizer vaccine.
hepatitis B nonresponder; Literature Report  This literature report has been received from authors of a published article, titled as above, regarding an adult patient. The medical history, current conditions and concomitant medications were not provided.  On an unknown date, the patient was vaccinated with initial series of hepatitis B vaccine (recombinant) (dose, frequency, route, lot# and expiration date were unknown) for prophylaxis at age of 58 (unit not provided). And the patient was vaccinated with the second series of hepatitis B vaccine (recombinant) (dose, frequency, route, lot# and expiration date were unknown) for prophylaxis at age of 61 (unit not provided) on an unknown date. Total number of standard hepatitis B vaccine (recombinant) doses were 6. The patient did not respond to two complete standard hepatitis B vaccine (recombinant) vaccine series and was termed as nonresponder (Vaccination failure). The outcome of vaccination failure was unknown.  The causality between vaccination failure and hepatitis B vaccine (recombinant) was related.  A copy of the published article is attached as further documentation of the patient's experience. ; Sender's Comments:  US-009507513-2207USA004701:
Shivering; Fever; Tiredness; Headache; Pain; Redness; Swelling; Arm is very itchy; This case was reported by a consumer via (Shingrix GSK) interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th December 2021 09:00, the patient received the 1st dose of Shingrix. On 13th December 2021, immediately after receiving Shingrix, the patient experienced pain, erythema and swelling. On 14th December 2021, the patient experienced shivering, fever, fatigue and headache. In December 2021, the patient experienced itchy upper limbs. On an unknown date, the outcome of the pain, erythema, swelling and itchy upper limbs were unknown and the outcome of the shivering, fever, fatigue and headache were recovering/resolving.   It was unknown if the reporter considered the pain, erythema, swelling, shivering, fever, fatigue, headache and itchy upper limbs to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received dose of Shingrix vaccine and almost immediately experienced pain, redness and swelling. The patient also experienced shivering, fever, tiredness, headache side effects started the evening of the 14th December 2021. That was seems to be getting better. But his/her arm was very itchy. The follow-up would not possible as no contact details were available.
extreme tiredness; she can't get out of bed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 02Sep2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 Immunization; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 immunization. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "extreme tiredness"; ASTHENIA (non-serious), outcome "unknown", described as "she can't get out of bed".  Additional information: Patient Stated that since the booster she had been late for work 9 times and on weekends she can't get out of bed and she has to to get to work. Caller stated it's terrible. Phone answered by the consumer who provided the mailing address.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Heavy Head; Tired; Chills; Diarrhea Symptoms; This is a spontaneous report from a contactable consumer (the patient). A 79-year-old female patient received the first dose and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 25Jan2021 15:00 (lot number El 9269) and on 12Feb2021 17:30 (lot number EL9262), respectively, both via an unspecified route of administration in the left arm (at the age of 79-years-old), as a single dose for COVID-19 immunization. The patient's medical history included: allergies to penicillium and sulphur. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. Concomitant medications included: atorvastatin, multivitamin, "vitamin C K E calcium". The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Jan2021 09:00, 4 days after the first dose, the patient experienced heavy head, tired, chills and diarrhea symptoms, lasted about 6 hours. The patient had to take 2 antidiarrhea pills. Seven days after the second dose, the patient experienced the same symptoms for the same amount of time. The patient did not receive treatment for heavy head, tired, chills. The clinical outcome of the events was recovered on an unspecified date. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Case number PHEH2013US026642 is an initial spontaneous report received from a pharmacist on 30 DEC 2013. This case refers to a 21 years old female patient. Her medical history, past drugs, current conditions and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: X12011), intramuscularly on 26 DEC 2013. On 27 DEC 2013, she experienced a large, painful red spot at the vaccination site that was about 5-6 inches in diameter. She also experienced sluggishness, fever and swollen lymph nodes. The outcome of the events was reported as condition unchanged. The seriousness and causality of the events were not reported.
Within about 24 hours of vaccines, child had redness, swelling and approximately 14cm knot to left thigh.
Experineced pain at injection site.  Ice was applied to injection site.  Recipient too 200mg of Advil.  Developed dizziness and nausea.  Vomited at 12:50 PM.  States that vomiting may have been due to anxiety. EMT and paramedic called to scene. BP 118/80. Felt better after vomiting.  Declined ambulance transfer.  Called mother to have her picked up from clinoc site.
pt exp fever & sweats for 2 to 3 days p/recvd Typhoid vax; in addition, pt devel edema of the inject arm;